introduct
studi
undertaken
estim
burden
morbid
associ
laboratoryconfirm
influenza
children
year
age
patient
method
children
present
acut
respiratori
infect
andor
isol
fever
basurto
univers
hospit
bilbao
spain
novemb
may
includ
studi
two
nasopharyng
secret
sampl
taken
one
rapid
influenza
diagnost
test
emerg
depart
second
laboratori
analysi
use
realtim
polymeras
chain
reaction
viral
cultur
result
total
children
recruit
hospit
influenza
diagnosi
confirm
children
treat
outpati
hospit
children
total
children
laboratori
test
posit
influenza
proport
subject
respiratori
virus
case
coinfect
influenza
viru
plu
anoth
respiratori
viru
pleas
cite
articl
ortizlana
n
garrot
e
j
rementeria
j
ja
mccoig
c
et
al
estudio
prospectivo
para
estimar
la
carga
de
visita
urgencia
de
la
gripe
en
en
bilbao
pediatr
barc
directo
medio
asociado
con
cada
caso
de
gripe
confirmada
fue
de
n
se
observaron
diferencia
significativa
entr
el
cost
asociado
con
gripe
b
casi
la
mitad
de
lo
caso
fueron
viru
de
gripe
b
la
de
una
vacuna
que
incluya
tipo
b
de
gripe
reducir
la
carga
de
la
enfermedad
detect
case
influenza
viru
type
b
victoria
yamagata
b
median
direct
medic
cost
associ
case
laboratoryconfirm
influenza
n
signific
differ
observ
medic
cost
associ
influenza
b
conclus
almost
half
case
influenza
viru
b
type
administr
vaccin
contain
influenza
b
type
children
year
age
might
reduc
overal
burden
ill
de
publish
elsevi
slu
right
reserv
servicio
de
urgencia
gripe
estudio
prospectivo
para
estimar
la
carga
de
visita
urgencia
de
la
gripe
en
en
bilbao
el
estudio
se
cabo
para
estimar
la
carga
de
enfermedad
de
la
gripe
confirmada
por
laboratorio
en
menor
de
pacient
lo
que
acudieron
al
hospit
universitario
de
basurto
con
de
respiratoria
aguda
yo
fiebr
aislada
entr
noviembr
de
mayo
de
fueron
incluido
en
el
estudio
se
tomaron
muestra
de
una
para
un
test
de
en
el
servicio
de
urgencia
otra
para
en
laboratorio
con
en
cadena
de
la
polimerasa
en
tiempo
real
cultivo
viral
resultado
se
un
total
de
de
lo
que
fueron
hospitalizado
el
de
gripe
se
en
fueron
tratado
ambulatoriament
hospitalizado
en
el
resultado
fue
positivo
la
de
otro
viru
respiratorio
fue
caso
de
con
otro
viru
respiratorio
de
gripe
de
lo
tipo
de
viru
de
gripe
fueron
b
victoria
yamagata
b
el
cost
introduct
influenza
highli
contagi
acut
respiratori
ill
caus
influenza
viru
associ
extens
array
clinic
symptom
rang
selflimit
respiratori
condit
upper
airway
system
repercuss
potenti
fatal
complic
influenza
usual
occur
form
annual
epidem
although
may
occasion
give
rise
pandem
world
health
organ
estim
influenza
caus
three
five
million
case
global
year
account
approxim
death
season
occur
european
union
breastfeed
infant
children
underli
patholog
adult
year
age
suscept
sever
form
diseas
howev
greatest
morbid
observ
pediatr
children
repres
main
transmitt
infect
diseas
children
also
associ
substanti
econom
social
burden
two
common
type
influenza
viru
affect
human
b
annual
influenza
epidem
usual
caus
minor
variant
type
almost
children
infect
first
year
life
acquir
protect
immun
exclus
particular
strain
viru
sinc
influenza
viru
capabl
natur
infect
numer
anim
speci
occasion
caus
pandem
gener
greater
concern
among
public
health
author
influenza
b
viru
affect
human
variat
influenza
type
wide
classifi
subtyp
base
ha
hemagglutinin
na
neuraminidas
membran
antigen
antigen
genet
differ
reveal
two
lineag
influenza
b
virus
victoria
yamagata
circul
simultan
around
globe
sinc
difficult
predict
lineag
domin
next
influenza
season
vaccin
influenza
effect
way
prevent
infect
complic
although
difficult
know
real
incid
ill
due
nonspecif
natur
symptom
accur
data
burden
medic
cost
associ
ill
essenti
develop
appropri
vaccin
polici
data
limit
spain
therefor
studi
design
quantifi
emerg
depart
visit
hospit
admiss
direct
medic
cost
attribut
laboratoryconfirm
influenza
children
year
age
present
hospit
acut
respiratori
infect
ari
andor
isol
fever
influenza
season
prospect
studi
conduct
basurto
univers
hospit
bilbao
spain
tertiari
hospit
gener
emerg
servic
novemb
may
influenza
pandem
accord
principl
good
clinic
practic
declar
helsinki
local
standard
studi
protocol
approv
ethic
committe
institut
board
inform
written
consent
obtain
parent
legal
guardian
children
year
age
older
children
inclus
children
year
age
present
emerg
depart
ari
influenza
season
defin
period
first
last
case
laboratoryconfirm
influenza
recruit
regardless
whether
subsequ
admit
hospit
ari
defin
presenc
least
one
follow
symptom
sore
throat
children
year
rhinorrhea
cough
andor
breath
difficulti
andor
isol
fever
oral
temperatur
cunderarm
temperatur
crectal
temperatur
c
eardrum
temperatur
adjust
oral
ceardrum
temperatur
adjust
rectal
c
two
clinic
specimen
throat
swab
andor
nasopharyng
swab
obtain
patient
case
medic
histori
review
includ
previou
vaccin
detail
concomit
medic
ari
andor
fever
associ
symptom
find
physic
examin
detail
record
directli
attend
pediatrician
studi
clinic
report
form
hospit
children
inform
clinic
cours
diseas
administ
treatment
complet
discharg
approxim
one
month
initi
visit
hospit
famili
contact
telephon
followup
interview
conduct
inform
concern
clinic
cours
diseas
requir
medic
assist
use
medic
prescrib
discharg
number
day
absent
school
number
contact
household
subsequ
develop
influenzalik
symptom
collect
use
data
hospit
administr
databas
medic
cost
associ
influenzalik
ill
calcul
includ
cost
medic
manag
emerg
depart
hospit
resourc
use
diagnosi
treatment
diseas
complic
order
rapidli
identifi
influenza
case
quick
diagnost
test
xpect
flu
b
remel
lenexa
ks
usa
perform
immedi
one
nasopharyng
sampl
collect
emerg
depart
regardless
result
remain
sampl
store
c
transport
valencian
microbiolog
institut
laboratori
medium
hank
buffer
salin
solut
hepe
buffer
gelatin
sodium
bicarbon
antibiot
penicillin
streptomycin
amphotericin
b
confirmatori
analysi
use
cultur
realtim
polymeras
chain
reaction
rtpcr
latter
determin
total
rna
extract
use
maxwel
viral
total
nucleic
acid
purif
kit
promega
madison
wi
usa
amplifi
use
multiplex
rtpcr
sens
revers
primer
doubl
mark
probe
identifi
influenza
type
b
respect
sampl
size
estim
requir
inclus
subject
attend
emerg
depart
ari
andor
isol
fever
base
expect
proport
laboratoryconfirm
influenza
infect
subject
hospit
collect
medic
cost
treatment
care
servic
patient
receiv
direct
medic
cost
children
laboratoryconfirm
influenza
calcul
hospit
administr
data
take
account
diagnost
medic
manag
influenza
treatment
visit
emerg
depart
inpati
charg
ward
specif
room
charg
intens
care
unit
icu
charg
confid
interv
ci
calcul
use
procstatxact
cytel
cambridg
usa
compar
test
posit
neg
influenza
group
carri
use
mann
whitney
test
ordin
continu
variabl
fisher
exact
test
categor
variabl
addit
exploratori
analys
perform
evalu
direct
medic
cost
symptom
need
subsequ
healthcar
assist
associ
influenza
type
b
children
recruit
novemb
april
suffici
data
avail
allow
evalu
case
subject
includ
final
analysi
children
seen
emerg
depart
children
requir
hospit
laboratoryconfirm
influenza
use
either
rapid
diagnost
test
cultur
rtpcr
analysi
perform
subject
demonstr
children
ci
ie
children
attend
emerg
depart
ci
hospit
case
ci
median
age
children
laboratoryconfirm
influenza
month
rang
month
male
tabl
among
case
laboratoryconfirm
influenza
requir
medic
reevalu
emerg
depart
follow
discharg
two
requir
hospit
tabl
subsequ
followup
visit
made
patient
regardless
influenza
statu
influenzaposit
subject
influenzaneg
subject
p
among
influenza
case
compar
proport
influenza
influenza
b
subsequ
followup
visit
p
time
last
contact
almost
children
recov
still
recov
overal
median
total
direct
medic
cost
associ
case
laboratoryconfirm
influenza
tabl
rang
cost
relat
rang
treatment
receiv
major
patient
emerg
depart
visit
median
patient
receiv
prescript
nonprescript
medic
median
around
patient
diagnost
cost
median
around
patient
incur
expens
ward
cost
median
patient
expens
icu
cost
median
children
laboratoryconfirm
influenza
miss
school
day
care
mean
absenc
day
rang
school
absenc
record
children
influenza
type
b
respect
proport
domest
contact
influenzalik
symptom
ari
andor
fever
studi
period
significantli
higher
among
children
laboratoryconfirm
influenza
ci
everi
year
greatest
incid
influenza
occur
children
inde
global
incid
rate
case
per
children
year
age
publish
univers
hospit
set
children
year
age
symptom
compat
influenzalik
infect
found
laboratoryconfirm
influenza
compar
matia
et
al
report
children
present
ari
isol
fever
spain
posit
influenza
pediatr
popul
influenza
respons
consider
number
visit
emerg
depart
hospit
absenc
school
repres
consider
econom
burden
year
inde
hospitalbas
studi
overal
median
direct
medic
cost
associ
influenza
appropri
vaccin
might
reduc
burden
observ
previous
spain
type
bposit
children
studi
older
type
aposit
subject
median
age
month
versu
month
respect
result
similar
studi
conduct
finland
correspond
mean
age
year
type
b
year
type
p
proport
type
b
among
influenza
virus
europ
vari
influenza
season
howev
accord
recent
report
european
centr
diseas
prevent
control
type
b
influenza
viru
domin
spain
affect
whole
spanish
popul
incid
rate
per
studi
proport
children
type
b
influenza
among
subject
laboratoryconfirm
diseas
result
similar
observ
matia
et
al
studi
similar
design
influenza
type
b
viru
detect
posit
influenza
case
spain
n
presenc
two
lineag
vari
among
influenza
case
season
depend
geograph
locat
vaccin
effect
way
prevent
infect
influenza
consequ
complic
econom
burden
influenza
strain
recommend
inclus
season
trival
vaccin
northern
hemispher
two
influenza
type
strain
analog
like
viru
strain
analog
like
viru
plu
victoria
lineag
influenza
type
b
strain
analog
viru
studi
major
laboratoryconfirm
case
type
b
influenza
correspond
victoria
strain
therefor
type
b
lineag
recommend
vaccin
correspond
type
b
circul
influenza
season
howev
either
lineag
type
b
influenza
victoria
yamagata
predomin
season
although
proport
strain
yamagata
lineag
low
studi
extens
season
variabl
observ
exampl
b
strain
yamagata
lineag
compar
notabl
recommend
use
tetraval
vaccin
ie
contain
lineag
type
b
type
influenza
season
northern
hemispher
limit
studi
may
affect
interpret
result
firstli
children
recruit
hospit
emerg
depart
case
like
seriou
subject
supplementari
test
compar
case
seen
primari
care
set
convers
avail
rapid
diagnost
test
result
mean
proport
children
present
isol
fever
subsequ
hospit
lower
test
avail
possibl
symptom
record
followup
telephon
interview
may
underreport
final
studi
took
place
singl
influenza
season
therefor
find
may
overor
underestim
influenza
burden
season
addit
sinc
proport
influenza
type
b
lineag
may
vari
would
interest
explor
situat
multipl
season
summari
influenza
respons
consider
burden
diseas
associ
cost
pediatr
popul
year
influenza
case
caus
strain
b
strain
appear
result
similar
burden
term
hospit
emerg
depart
cost
could
partial
allevi
appropri
vaccin
proport
influenza
type
b
season
similar
lineag
influenza
type
b
victoria
yamagata
detect
among
case
laboratoryconfirm
influenza
studi
although
percentag
yamagata
lineag
low
influenza
season
studi
good
match
influenza
strain
vaccin
circul
strain
vaccin
protect
strain
victoria
b
lineag
season
mismatch
howev
vaccin
like
provid
less
protect
given
burden
influenza
shown
studi
give
children
year
age
vaccin
contain
lineag
influenza
type
type
b
might
help
reduc
overal
burden
ill
due
difficulti
predict
viru
strain
respons
futur
influenza
season
use
tetraval
vaccin
protect
b
lineag
strain
addit
strain
may
provid
broadest
protect
glaxosmithklin
biolog
sa
sponsor
fund
studi
conduct
analys
data
develop
public
manuscript
